Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL3 | Q96JM7 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13654343 | 0.84 | — | — | |
| SCHEMBL13383211 | 0.84 | — | — | |
| SCHEMBL13654348 | 0.84 | — | — | |
| SCHEMBL23119354 | 0.79 | — | — | |
| SCHEMBL17284223 | 0.79 | L3MBTL3 (0.47) | L3MBTL3L3MBTL1 | |
| SCHEMBL23653975 | 0.75 | SLC6A4 (0.33) | — | |
| SCHEMBL27985431 | 0.74 | L3MBTL3 (0.42) | L3MBTL3L3MBTL1TDP1 | |
| SCHEMBL46703 | 0.74 | L3MBTL3 (0.42) | L3MBTL3L3MBTL1 | |
| SCHEMBL23682812 | 0.72 | L3MBTL3 (0.45) | L3MBTL3L3MBTL1TDP1 | |
| SCHEMBL20926955 | 0.72 | L3MBTL3 (0.41) | L3MBTL3L3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021216440-A1 | NOVEL PROTEIN KINASE INHIBITORS | TENOVA PHARMACEUTICALS INC. (US) | 2021-10-28 | — | — | WO | disclosed |
| WO-2021047646-A1 | SUBSTITUTED IMIDAZOQUINOXALINE COMPOUNDS AND USES THEREOF | IMPACT THERAPEUTICS, INC (CN) | 2021-03-18 | — | — | WO | disclosed |
| WO-2021004482-A1 | SUBSTITUTED PYRAZOLOQUINAZOLONE COMPOUND AND APPLICATION THEREOF | 上海瑛派药业有限公司 | 2021-01-14 | — | — | WO | disclosed |
| EP-3555063-B1 | 6-AMINO-QUINOLINONE COMPOUNDS AND DERIVATIVES AS BCL6 INHIBITORS | BOEHRINGER INGELHEIM INT (DE) | 2020-09-16 | — | — | EP | disclosed |
| WO-2018127195-A1 | SUBSTITUTED FUSED HETEROARYL COMPOUND SERVING AS A KINASE INHIBITOR, AND APPLICATIONS THEREOF | 上海瑛派药业有限公司 | 2018-07-12 | — | — | WO | disclosed |
| WO-2018108704-A1 | NEW 6-AMINO-QUINOLINONE COMPOUNDS AND DERIVATIVES AS BCL6 INHIBITORS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2018-06-21 | — | — | WO | disclosed |
| WO-2017192228-A1 | PAK1 INHIBITORS AND USES THEREOF | ALBERT EINSTEIN COLLEGE OF MEDICINE, INC. (US) | 2017-11-09 | — | — | WO | disclosed |
| EP-2882733-B1 | SUBSTITUTED AZINES AS PESTICIDES | NOVARTIS TIERGESUNDHEIT AG (CH) | 2017-04-26 | — | — | EP | disclosed |
| US-9604984-B2 | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds, compositions and methods of use thereof | GENENTECH, INC. (US) | 2017-03-28 | — | — | US | disclosed |
| WO-2015177326-A1 | 5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS WHICH ARE JAK INHIBITORS | F. HOFFMANN-LA ROCHE AG (CH) | 2015-11-26 | — | — | WO | disclosed |
| WO-2012038081-A1 | SUBSTITUTED BENZAMIDE COMPOUNDS | Grünenthal GmbH (DE) | 2012-03-29 | — | — | WO | disclosed |